Harmony Consulting Blog
For decades, biotech manufacturing thrived on globalization. A molecule might be discovered in Boston, scaled in Singapore, and filled and finished in Ireland — all part of an intricate web…
Scaling a promising therapeutic from lab bench to commercial production is one of the most defining transitions in a biotech’s lifecycle. It’s also one of the most closely scrutinized. As…
When the federal government shuts down, Washington D.C. doesn’t actually close — it constricts. For biotech organizations that rely on federal grants, contracts, regulatory interactions or collaborations with government-labs, a…
Phase-Appropriate Development: #2 We need to comply with FDA requirements. How much is enough? If the basics are not in place, then development will not move forward. Studies will need…
Phase-Appropriate Development: Part#1 FDA-regulated companies are always being told to do more. There are multiple new guidance documents per year, revisions of old rules, new technologies, new tests, new contaminants.…
- « Previous
- 1
- 2